AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in AbCellera Biologics Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 183
- −18 vs. Q4 2022
- Shares held
- 130.1M
- +2.15M (+1.7%) vs. Q4 2022
- Total value
- $980.7M
- −$315.8M (−24.4%) vs. Q4 2022
- New holders
- 22
- 64 more added
- Sold out
- 40
- 54 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABCL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $908.8M |
| Q1 2026 | 138 | $434.0M |
| Q4 2025 | 144 | $370.6M |
| Q3 2025 | 141 | $524.6M |
| Q2 2025 | 128 | $370.6M |
| Q1 2025 | 129 | $280.1M |
| Q4 2024 | 146 | $333.9M |
| Q3 2024 | 139 | $274.6M |
| Q2 2024 | 148 | $338.3M |
| Q1 2024 | 154 | $547.4M |
| Q4 2023 | 143 | $681.1M |
| Q3 2023 | 138 | $551.8M |
| Q2 2023 | 170 | $809.1M |
| Q1 2023 | 183 | $980.7M |
| Q4 2022 | 203 | $1.30B |
| Q3 2022 | 190 | $1.21B |
| Q2 2022 | 162 | $1.26B |
| Q1 2022 | 130 | $1.10B |
| Q4 2021 | 124 | $1.63B |
| Q3 2021 | 116 | $1.98B |
| Q2 2021 | 114 | $1.99B |
| Q1 2021 | 86 | $2.42B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding AbCellera Biologics Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 0 | $0 | 0.00% | −32,598−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −32,546−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −31,640−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −25,818−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −24,813−100.0% | Sold out |
| Prudential PLC | 0 | $0 | 0.00% | −24,012−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −20,557−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −19,897−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −18,282−100.0% | Sold out |
| Cornerstone Investment Partners, LLC | 0 | $0 | 0.00% | −17,725−100.0% | Sold out |
| Counterpoint Mutual Funds LLC | 0 | $0 | 0.00% | −15,625−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −15,031−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −11,459−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −9,400−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −8,900−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −1,861−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −517−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Financial Synergies Wealth Advisors, Inc. | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −348−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −348−100.0% | Sold out |
| Neo Ivy Capital Management | – | – | – | – | Not filed |
| Trustcore Financial Services, LLC | – | – | – | – | Not filed |